D Hahn

615 total citations
21 papers, 83 citations indexed

About

D Hahn is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, D Hahn has authored 21 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Otorhinolaryngology and 5 papers in Surgery. Recurrent topics in D Hahn's work include Head and Neck Cancer Studies (9 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Sarcoma Diagnosis and Treatment (3 papers). D Hahn is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Sarcoma Diagnosis and Treatment (3 papers). D Hahn collaborates with scholars based in Germany, Switzerland and Austria. D Hahn's co-authors include Dietmar Reichert, Christiane Pott, Ioannis Anagnostopoulos, Heiner Zimmermann, Matthias Ritgen, Ralf Ulrich Trappe, Mirko Nitsche, Mathias Rummel, Orlando Guntinas‐Lichius and Michael Heuser and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Leukemia.

In The Last Decade

D Hahn

18 papers receiving 80 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Hahn Germany	6	52	24	24	14	10	21	83
M. Cavallari Italy	5	24 0.5×	17 0.7×	10 0.4×	9 0.6×	13 1.3×	11	51
Mahesh Sultania India	6	50 1.0×	15 0.6×	32 1.3×	10 0.7×	48 4.8×	32	101
Gabriel Raab United States	5	44 0.8×	10 0.4×	22 0.9×	5 0.4×	28 2.8×	15	92
Jae‐Keun Cho South Korea	7	73 1.4×	47 2.0×	10 0.4×	4 0.3×	84 8.4×	10	133
A L Klochikhin Spain	4	43 0.8×	36 1.5×	17 0.7×	3 0.2×	22 2.2×	14	66
S. Marimuthu United States	4	35 0.7×	32 1.3×	30 1.3×	5 0.4×	25 2.5×	5	69
Ahmed Mostafa Egypt	6	13 0.3×	8 0.3×	20 0.8×	8 0.6×	39 3.9×	19	89
Xuping Xi China	5	30 0.6×	59 2.5×	37 1.5×	5 0.4×	16 1.6×	9	96
Nick Wadd United Kingdom	5	45 0.9×	3 0.1×	30 1.3×	16 1.1×	28 2.8×	10	83
Sharon Shuxian Poh Singapore	5	40 0.8×	28 1.2×	16 0.7×	3 0.2×	19 1.9×	10	66

Countries citing papers authored by D Hahn

Since Specialization

Citations

This map shows the geographic impact of D Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Hahn more than expected).

Fields of papers citing papers by D Hahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Hahn. The network helps show where D Hahn may publish in the future.

Co-authorship network of co-authors of D Hahn

This figure shows the co-authorship network connecting the top 25 collaborators of D Hahn. A scholar is included among the top collaborators of D Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Hahn. D Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paschold, Lisa, Christoph Schultheiß, Konrad Klinghammer, et al.. (2025). Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer. npj Precision Oncology. 9(1). 272–272.

Brandt, Anna, Christoph Schultheiß, Konrad Klinghammer, et al.. (2024). Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS trial. Frontiers in Oncology. 14. 1283266–1283266. 7 indexed citations

Bielack, Stefan, Lars H. Lindner, Gerlinde Egerer, et al.. (2023). Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group. Journal of Geriatric Oncology. 14(3). 101445–101445. 1 indexed citations

Zimmermann, Heiner, Christian Koenecke, Martin Dreyling, et al.. (2022). Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial. Leukemia. 36(10). 2468–2478. 15 indexed citations

Grünwald, Viktor, Daniel Pink, Gerlinde Egerer, et al.. (2022). 1496P Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, prospective, multicenter study. Annals of Oncology. 33. S1231–S1231. 1 indexed citations

Zimmermann, Heiner, Mirko Nitsche, Christiane Pott, et al.. (2021). Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry. Annals of Hematology. 100(8). 2043–2050. 8 indexed citations

Hecht, Markus, D Hahn, Matthias Hautmann, et al.. (2021). A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer. Cancers. 13(14). 3413–3413. 5 indexed citations

Hahn, D, Boris Kubuschok, Ulrike Bockmühl, et al.. (2021). 924P HANNA: Effectiveness and quality-of-life data from a real-world study of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab in Germany. Annals of Oncology. 32. S813–S813.

Gruenwald, Viktor, Ullrich Graeven, Philipp Ivanyi, et al.. (2021). 912P Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115). Annals of Oncology. 32. S807–S808. 3 indexed citations

10.

Hecht, Markus, D Hahn, Matthias Hautmann, et al.. (2020). Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer. BMC Cancer. 20(1). 933–933. 9 indexed citations

11.

Dietz, Andreas, Manfred Welslau, D Hahn, et al.. (2020). HANNA: Real-world outcomes from an observational study with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in Germany.. Journal of Clinical Oncology. 38(15_suppl). 6532–6532. 4 indexed citations

12.

Trappe, Ralf Ulrich, Christian Koenecke, Martin Dreyling, et al.. (2020). Treatment stratification in B-cell PTLD after solid organ transplantation (SOT) by international prognostic index (IPI) and response to rituximab: Interim results from the PTLD-2 trial.. Journal of Clinical Oncology. 38(15_suppl). 8045–8045. 2 indexed citations

13.

Hecht, Markus, D Hahn, Dirk Beutner, et al.. (2016). Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial). Annals of Oncology. 27. vi343–vi343. 4 indexed citations

14.

Jenett, M., et al.. (2005). Niedrigdosis-CT der Lunge bei neutropenischen Patienten mit unklarem Fieber. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 177(10). 1424–1429. 4 indexed citations

15.

Hahn, D, et al.. (2005). Gulf of Mexico Shelf Deep Ultra-HP/HT Completions - Current Technology Gaps. Proceedings of SPE Annual Technical Conference and Exhibition. 1 indexed citations

16.

Hahn, D, et al.. (2005). Gulf of Mexico Shelf Deep Ultra HPHT Completions - Current Technology Gaps. 2 indexed citations

17.

Keberle, M., J Sandstede, Florian Hoppe, M Fischer, & D Hahn. (2004). Diagnostischer Nutzen multiplanarer Reformationen bei der Mehrschicht-CT von Larynx- und Hypopharynxkarzinomen. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 176(S 1). 2 indexed citations

18.

Keberle, M., et al.. (2001). Untersucherabhängigkeit der CT von Oro- und Hypopharynxkarzinomen. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 173(7). 583–590. 2 indexed citations

19.

Naegele, Matthias, A. E. Goetz, Fernando Gamarra, et al.. (1989). Gd-DTPA-gestützte kernspintomographische Perfusionskontrolle von stoßwellentherapierten Tumoren. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 150(5). 602–605. 3 indexed citations

20.

Moser, Elizabeth Charlotte, et al.. (1983). [Value of posttherapeutic scintigraphy for the demonstration of distant metastases of differentiated carcinomas of the thyroid gland].. PubMed. 159(4). 217–23. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact